Therefore, we can support that immunohistochemical homogeneous PTEN loss is predominantly linked to ERG fusions (ERG-positive immunostaining), a mechanism mostly seen in prostate adenocarcinomas of low grade. Here, ERG is linked to prostate adenocarcinoma.